Lilly’s Mounjaro tops other GLP-1s for some type 2 diabetes patients
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and…
Immune scaffold predicts onset weeks early
A retrievable immune scaffold reveals a 5–7 week presymptomatic window for tracking type 1 diabetes progression, long before…